A New Cellular Signaling Mechanism for Angiotensin II Activation of NF-&kgr;B: An I&kgr;B–Independent, RSK–Mediated Phosphorylation of p65

Objective—Angiotensin II (Ang II) promotes vascular inflammation and remodeling via activation of nuclear factor &kgr;B (NF-&kgr;B)–mediated transcription of proinflammatory genes such as interleukin-6 (IL-6). We examined the signaling mechanism whereby Ang II activates NF-&kgr;B in vascular smooth muscle cells (VSMCs). Methods and Results—Ang II treatment did not increase phosphorylation of inhibitor of &kgr;B&agr; (I&kgr;B&agr;) or I&kgr;B&bgr; or decrease their levels. In contrast, mitogen-activated protein kinase kinase-1 (MEK1) inhibition (dominant-negative MEK1 adenovirus or inhibitor U0126) suppressed Ang II–induced NF-&kgr;B promoter activity, NF-&kgr;B DNA-binding activity, p65 phosphorylation, and led to 70% reduction in IL-6 transcription/production. The mechanism involved Ang II activation of Ras and MEK1. Signaling distal to MEK1 involved extracellular signal-regulated kinase (ERK) because inhibition of MEK1 suppressed the Ang II–induced activation of ribosomal S6 kinase (RSK), a substrate of ERK. Downregulation of RSK by small interfering RNA (SiRNA) in VSMCs was found to suppress Ang II–induced activation of NF-&kgr;B and p65 phosphorylation. Immunopurified RSK from Ang II–treated VSMCs phosphorylated recombinant glutathione S-transferase–p65 in vitro. Conclusion—We uncovered a nonclassical signaling pathway (Ras/MEK1/ERK/RSK) from Ang II to activation of NF-&kgr;B, a mechanism by which Ang II stimulates RSK-mediated phosphorylation of p65 to participate in vascular inflammation.

[1]  A. Saxon Faculty Opinions recommendation of Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. , 2004 .

[2]  M. Schmitz,et al.  Transient and Selective NF-κB p65 Serine 536 Phosphorylation Induced by T Cell Costimulation Is Mediated by IκB Kinase β and Controls the Kinetics of p65 Nuclear Import 1 , 2004, The Journal of Immunology.

[3]  M. Davies,et al.  The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis , 1993, The Journal of pathology.

[4]  J. Egido,et al.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. , 1997, Circulation.

[5]  Y. Xia,et al.  Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. , 1993, Archives of biochemistry and biophysics.

[6]  S. Impey,et al.  Mitogen- and Stress-Activated Protein Kinase 1 Mediates cAMP Response Element-Binding Protein Phosphorylation and Activation by Neurotrophins , 2004, The Journal of Neuroscience.

[7]  A. Gown,et al.  Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. , 1992, The American journal of pathology.

[8]  T. Drake,et al.  Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. , 1995, Circulation.

[9]  Yusuke Suzuki,et al.  Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. , 2004, Journal of the American Society of Nephrology : JASN.

[10]  H. Kang,et al.  Extracellular Signal-regulated Kinase/90-kDa Ribosomal S6 Kinase/Nuclear Factor-κB Pathway Mediates Phorbol 12-Myristate 13-Acetate-induced Megakaryocytic Differentiation of K562 Cells* , 2001, The Journal of Biological Chemistry.

[11]  F. Thaiss,et al.  Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. , 2002, Kidney international.

[12]  N. Colburn,et al.  Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. , 2004, Carcinogenesis.

[13]  G. Ferns,et al.  Markers of inflammation and coronary artery disease. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[14]  W. Gonzalez,et al.  Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Egido,et al.  Inflammation and angiotensin II. , 2003, The international journal of biochemistry & cell biology.

[16]  E. Plow,et al.  A role for intercellular adhesion molecule-1 in restenosis. , 1997, Circulation.

[17]  P. Libby,et al.  Angiotensin induces inflammatory activation of human vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[18]  W. Greene,et al.  p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.

[19]  M. Runge,et al.  Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. , 1999, Circulation research.

[20]  A. Fowler,et al.  Atypical mechanism of NF-kappaB activation during reoxygenation stress in microvascular endothelium: a role for tyrosine kinases. , 2002, Free radical biology & medicine.

[21]  W. Greene,et al.  p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. , 2004, The Journal of biological chemistry.

[22]  D. Scheuner,et al.  Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis. , 2004, Journal of Biological Chemistry.

[23]  P. Delafontaine,et al.  Distinct and Common Pathways in the Regulation of Insulin-like Growth Factor-1 Receptor Gene Expression by Angiotensin II and Basic Fibroblast Growth Factor* , 1999, The Journal of Biological Chemistry.

[24]  Jian-Mei Li,et al.  Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. , 2004, Molecular endocrinology.

[25]  G. Daughters,et al.  Allograft Rejection , 2005 .

[26]  M. Schmitz,et al.  Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. , 2004, Journal of immunology.

[27]  D. Scheuner,et al.  Ultraviolet Light Activates NFκB through Translational Inhibition of IκBα Synthesis* , 2004, Journal of Biological Chemistry.